VoxelCloud (www.voxelcloud.io), a startup specializing in medical synthetic intelligence, has raised $8M in collection A financing led by Sequoia Capital. The startup makes use of synthetic intelligence and cloud-computing applied sciences to supply automated medical picture evaluation and medical resolution assist for medical practitioners.
The Los Angeles, CA-based firm plans to make use of its Collection A funding for increasing its scope of medical picture evaluation companies, establishing additional collaboration with main medical establishments in China and within the US, in addition to regulatory filings and advertising and marketing.
Based in 2015, VoxelCloud goals to supply correct, accessible, and personalised medical picture evaluation by constructing medical picture information graph primarily based on medical semantics and a number of synthetic intelligence fashions. The information graph can be provided within the type of an API to builders, permitting them to give attention to constructing options for particular medical purposes with out having to develop the essential algorithms and gather large quantity of anonymized coaching knowledge from scratch. Additional extension of the undertaking will leverage heterogeneous knowledge sources in synergy with the prevailing imaging knowledge.
Presently, the corporate has developed merchandise masking lung most cancers, retinal illnesses, coronary coronary heart illness and liver illness.
“VoxelCloud applies the most recent of AI know-how to ship extremely optimized medical workflows and empower physicians to make knowledgeable medical selections,” stated Xiaowei Ding, Co-Founder and CEO of VoxelCloud. “It is usually essential to acknowledge the present limitations of AI and correctly outline its function in immediately’s clinics. We’ll proceed our imaginative and prescient of delivering viable options that mix cutting-edge algorithms, state-of-the-art engineering, and strong medical context in an optimum method, and supply tangible worth to suppliers, sufferers, and builders.”
The founders of the startup come from the main analysis establishments and universities, all skilled scientists in medical picture evaluation and machine studying. In September 2016, the startup raised $5.5 M in angel funding.
“Now we have lengthy believed within the huge potential of synthetic intelligence in drugs,” stated a consultant from Sequoia Capital. “Our partnership with VoxelCloud can be pushed by this imaginative and prescient. We’re excited to witness this innovation and be a part of it by means of our funding in VoxelCloud.”